Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies

Authors: Kim Papp, Jacek C. Szepietowski, Leon Kircik, Darryl Toth, Lawrence F. Eichenfield, Donald Y.M. Leung, Seth Forman, May E. Venturanza, Kang Sun, Michael E. Kuligowski, Eric L. Simpson - Journal of the American Academy of Dermatology 2021 cited by 297